Michael Petusky
Stock Analyst at Barrington Research
(0)
# 4063
Out of 5,218 analysts
173
Total ratings
46.48%
Success rate
-3.73%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Haemonetics | Maintains: Outperform | 108 108 | 81.16 | 33.07% | 22 | Dec 4, 2024 | |
US Physical Therapy | Maintains: Outperform | 108 108 | 93.33 | 15.72% | 21 | Nov 21, 2024 | |
ModivCare | Maintains: Outperform | 25 25 | 17.91 | 39.59% | 12 | Nov 18, 2024 | |
VerifyMe | Maintains: Outperform | 2 2 | 0.62 | 141.94% | 8 | Nov 13, 2024 | |
OPKO Health | Maintains: Outperform | 3 3 | 1.59 | 41.51% | 9 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 24 | 19.75 | 21.52% | 17 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 82 82 | 76.59 | 7.06% | 11 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 92 93 | 100.34 | -7.32% | 8 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 25 | 17.14 | 45.86% | 15 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 114 114 | 102.83 | 10.86% | 15 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 32 | 23.5 | 36.17% | 11 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 6 | Aug 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 6 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 12 | n/a | n/a | 6 | Oct 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jul 27, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | n/a | n/a | 1 | Jun 9, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Dec 18, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 1 | Aug 3, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 1 | Aug 11, 2016 |